Our previous studies suggest that Mel-18 is a physiologic regulator of Bmi-1 expression and transcriptionally down-regulates Bmi-1 expression during senescence in human fibroblasts and acts as a tumor suppressor in breast cancer [38,43]. Here, PCGF2 is linked to neoplasm.